D
Organogenesis Holdings Inc. ORGO
$4.88 $0.214.50% NASDAQ
Recommendation
Prev Close
$4.67
Volume
1,879,310
Avg Vol (90D)
1,613,853
Market Cap
$592.29M
Dividend & Yield
--
52-Week Range
$2.21 - $6.71
P/E (TTM)
--
EPS (TTM)
-$0.0199
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
97,950 Shares in Organogenesis Holdings Inc. (NASDAQ:ORGO) Bought by Jump Financial LLC
4/29/2025 - MarketBeat
73,172 Shares in Organogenesis Holdings Inc. (NASDAQ:ORGO) Acquired by XTX Topco Ltd
4/29/2025 - MarketBeat
Organogenesis Holdings (ORGO, $4.45) price moved above its 50-day Moving Average on April 23, 2025
4/24/2025 - Tickeron - Technical Analysis
Organogenesis Holdings (ORGO, $4.21) Moving Average Convergence Divergence (MACD) Histogram turned positive on April 21, 2025
4/22/2025 - Tickeron - Stocks
Organogenesis Holdings (ORGO, $4.25) entered Downtrend as Momentum indicator drops below 0 level on Apr 16, 2025
4/17/2025 - Tickeron - Technical Analysis
Organogenesis (NASDAQ:ORGO) Trading Down 3.8% - Should You Sell?
4/16/2025 - MarketBeat
Organogenesis Holdings (ORGO, $4.32) price exceeded its 50-day Moving Average on April 15, 2025
4/16/2025 - Tickeron - Stocks
Organogenesis Holdings (ORGO, $4.33) price moved above its 50-day Moving Average on April 14, 2025
4/15/2025 - Tickeron - Stocks
Organogenesis Holdings (ORGO, $4.26) Stochastic Oscillator left the oversold zone on April 11, 2025
4/12/2025 - Tickeron - Stocks
Organogenesis Holdings (ORGO, $4.26) Aroon Indicator entered a Downtrend on April 11, 2025.
4/12/2025 - Tickeron - Stocks
Organogenesis Supports CMS' Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness
4/11/2025 - Globe Newswire
Organogenesis Holdings (ORGO, $3.75) Aroon Indicator entered a Downtrend on April 10, 2025.
4/11/2025 - Tickeron - Technical Analysis
Organogenesis Holdings (ORGO, $4.08) RSI Indicator left the oversold zone on April 09, 2025
4/10/2025 - Tickeron - Stocks
Organogenesis Holdings (ORGO, $4.08) Aroon Indicator entered a Downtrend on April 09, 2025.
4/10/2025 - Tickeron - Stocks
Organogenesis Holdings (ORGO, $3.7) RSI Indicator left the oversold zone on April 08, 2025
4/9/2025 - Tickeron - Technical Analysis
Organogenesis Holdings (ORGO, $3.7) Aroon Indicator entered a Downtrend on April 08, 2025.
4/9/2025 - Tickeron - Technical Analysis
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on ...
4/7/2025 - GuruFocus
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025
4/7/2025 - Globe Newswire
Insider-Favored Growth Companies Including Organogenesis Holdings And Two More
4/4/2025 - Simply Wall St
Organogenesis Holdings (ORGO, $4.07) price exceeded its 50-day Moving Average on April 03, 2025
4/4/2025 - Tickeron - Stocks
Analysts See 22% Upside For The Holdings of AVUS
4/2/2025 - ETF Channel
Organogenesis Holdings (ORGO, $4.32) price may climb as it broke lower Bollinger Band on Mar 31, 2025
4/1/2025 - Tickeron - Stocks
Organogenesis Holdings (ORGO, $4.67) Stochastic Oscillator left the oversold zone on March 27, 2025
3/28/2025 - Tickeron - Technical Analysis
Organogenesis (NASDAQ:ORGO) Stock Price Down 5.8% - Should You Sell?
3/27/2025 - MarketBeat
Organogenesis Holdings (ORGO, $4.7) price may climb as it broke lower Bollinger Band on Mar 26, 2025
3/27/2025 - Tickeron - Stocks
Income Statement
Total Revenue (TTM)
$482.04M
EBITDA (TTM)
$38.54M
EBIT (TTM)
$21.52M
Net Income (TTM)
$861.00K
Balance Sheet
Total Assets (Q)
$497.89M
Total Debt (Q)
$43.31M
Total Liabilities (Q)
$112.57M
Book Value Per Share (Q)
$2.09
Cash Flow
Cash from Operations (TTM)
$14.21M
Cash from Investing (TTM)
-$10.03M
Cash from Financing (TTM)
$27.64M
Net Change in Cash (TTM)
$31.81M
Filings
Filing Date
Thursday, February 27, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
1.71
7-Day Total Return
15.64%
30-Day Total Return
-1.81%
60-Day Total Return
32.61%
90-Day Total Return
37.46%
Year to Date Total Return
61.06%
1-Year Total Return
98.78%
2-Year Total Return
142.79%
3-Year Total Return
-24.22%
5-Year Total Return
29.44%
52-week Low
May 09, 2024 - $2.21
52-week High
Mar 03, 2025 - $6.71
Valuation
Market Cap
$592.29M - Small Cap
Enterprise Value
$622.14M
Price/Sales (TTM)
1.28
Price/Book (Q)
2.23
Dividends and Shares
Shares Outstanding
132.16M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
organogenesis.com
Phone Number
781 575 0775
Address
85 Dan Road
Canton, MA 02021
Country
United States
Year Founded
--
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures, and commercializes products for the advanced wound care, and surgical and sports medicine markets in the... more
NASDAQ 04/29/2025 4:00PM Eastern Quotes delayed